A company once keen to mirror the crypto-first playbooks of Silicon Valley has quietly redrawn its priorities.
Prenetics Global, the Nasdaq-listed health sciences firm backed by David Beckham, has decided that its future growth will be driven less by Bitcoin and more by vitamins.
The Hong Kong-founded group has halted its Bitcoin buying programme and is now channelling its energy into IM8, a fast-growing nutrition supplement brand it believes offers a clearer path to long-term value.
Bitcoin Buying Paused As Strategy Is Rewritten
Prenetics confirmed it stopped accumulating Bitcoin on 4 December 2025 and will not restart purchases in the future.
The decision was unanimously approved by its board, which concluded that further capital would be better deployed elsewhere.
The company currently holds 510 Bitcoin, valued at around $45 million, which it will keep as a treasury reserve asset.
However, it has committed to allocating no existing or new capital towards additional Bitcoin acquisitions.
Chief executive Danny Yeung framed the move as a calculated reset rather than a retreat.
“Operating from a position of strength, we are making disciplined strategic decisions that reflect our experience as operators and our commitment to maximizing long-term shareholder value.”
From Daily Bitcoin Buys To A Full Stop
The shift marks a sharp change in direction.
Prenetics began its Bitcoin treasury strategy in mid-2025, inspired by approaches popularised by Michael Saylor’s Strategy.
By August, it had launched an ambitious “1 BTC per day” plan, steadily building its holdings.
In October, the company raised $48 million in an oversubscribed equity round, partly to accelerate Bitcoin purchases.
At the time, it spoke openly about a long-term ambition to build a $1 billion Bitcoin position within five years.
That vision has now been shelved, less than three months after the fundraise, as market conditions deteriorated and crypto prices slid into a prolonged downturn.
IM8 Takes Centre Stage
Instead, Prenetics is betting on IM8, a premium supplement brand co-founded by David Beckham and endorsed by tennis world number one Aryna Sabalenka.
The company says the brand has already reached $100 million in recurring revenue within its first 11 months, a milestone that reshaped internal priorities.
IM8 is projected to generate between $160 million and $200 million in revenue in 2026, figures that have convinced management it represents a stronger and more predictable growth engine than digital assets.
Prenetics said it is now dedicating its resources and leadership attention entirely to scaling IM8, describing it as a “once-in-a-generation” brand opportunity.
A Wider Pullback Across Crypto Treasuries
Prenetics is not alone in changing course.
As Bitcoin entered a bear market in recent months, several digital-asset treasury firms have either slowed or abandoned their crypto accumulation strategies.
Companies that once used aggressive Bitcoin buying to attract investors have been forced to rethink as share prices fell and volatility returned.
Earlier this month, Peter Thiel-backed Ethereum treasury firm ETHZilla closed its crypto treasury altogether, selling $74.5 million worth of ETH.
The reversal highlights growing unease around crypto-heavy balance sheets, particularly for firms whose core businesses lie outside digital assets.
When Focus Becomes The New Currency
Coinlive sees Prenetics’ pivot as a sign of a maturing market rather than a loss of faith in Bitcoin.
Holding 510 BTC keeps optionality on the balance sheet, but redirecting capital towards a proven consumer brand reflects a broader shift.
Investors are rewarding clear revenues and execution over financial engineering.
In a colder crypto climate, conviction alone is no longer enough.
Companies are increasingly judged on where they can grow with confidence, not just where they can speculate.